Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sybille Muller

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Reviews of Immunology|September 17, 2004
Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine developmentSybille Muller
Journal of Medical Primatology|October 23, 2002
An immuno-logic hypothesisHeinz Kohler, Sybille Muller
Frontiers in Oncology|February 24, 2016
The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C VirusSybille Muller, Matthew S Parsons, Heinz Kohler, et al.
Drug Discovery Today|October 11, 2005
Therapeutic applications of superantibodiesYunfeng Zhao, Michael Russ, Charles Morgan, et al.
Expert Opinion on Biological Therapy|March 11, 2005
TransMabs: cell-penetrating antibodies, the next generationSybille Muller, Yunfeng Zhao, Thomas L Brown, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?Matthew S Parsons, Sybille Muller, Heinz Kohler, et al.
Cancer Immunology, Immunotherapy : CII|August 10, 2006
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibodyYunfeng Zhao, Michael Russ, Marc Retter, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Reviews of Immunology|September 17, 2004
Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine developmentSybille Muller
Journal of Medical Primatology|October 23, 2002
An immuno-logic hypothesisHeinz Kohler, Sybille Muller
Frontiers in Oncology|February 24, 2016
The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C VirusSybille Muller, Matthew S Parsons, Heinz Kohler, et al.
Drug Discovery Today|October 11, 2005
Therapeutic applications of superantibodiesYunfeng Zhao, Michael Russ, Charles Morgan, et al.
Expert Opinion on Biological Therapy|March 11, 2005
TransMabs: cell-penetrating antibodies, the next generationSybille Muller, Yunfeng Zhao, Thomas L Brown, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?Matthew S Parsons, Sybille Muller, Heinz Kohler, et al.
Cancer Immunology, Immunotherapy : CII|August 10, 2006
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibodyYunfeng Zhao, Michael Russ, Marc Retter, et al.
Pageof 1